0
Turnstone Biologics Corp. Banner Image

Turnstone Biologics Corp.

  • Ticker TSBX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Turnstone Biologics Corp. Logo Image
  • 51-200 Employees
  • Based in San Diego, California
Turnstone Biologics is a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy. Turnstone’s next-generation TIL therapy is based upon the identification, selection and expansion of the most potent tumor-reactive T cells, known as Selected TILs, andMore is designed to overcome the limitations of first-generation bulk TIL that have demonstrated objective responses only in limited tumor types. Turnstone’s most advanced program, TIDAL-01, is currently being evaluated in multiple Phase 1 studies in patients with colorectal cancer, breast cancer, head and neck cancer, uveal melanoma, and cutaneous melanoma. The Company is also actively advancing its preclinical pipeline programs including TIDAL-02, its next Selected TIL program, and its TIDAL-01 and viral immunotherapy combination program.
Turnstone Biologics Corp.

Most Recent Annual Report

Turnstone Biologics Corp.
MOST RECENT 2023 Annual Report and Form 10K
Turnstone Biologics Corp. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!